Household drinks brands Lucozade and Ribena are set to be put up for sale for as much as €1.1bn, it was reported today.

The UK’s Office of Fair Trading (OFT) has accused GlaxoSmithKline of paying generic manufacturers to delay the production of a generic equivalent of its antidepressant paroxetine, which it makes in Cork.

Drugs giant GlaxoSmithKline was today accused by the UK's competition watchdog of paying off firms to delay the launch of cheap versions of its antidepressant treatment in a move that denied the British National Health Service “significant” cost savings.